SATB2 induction of a neural crest mesenchyme-like program drives melanoma invasion and drug resistance.
Fazio M, van Rooijen E, Dang M, van de Hoek G, Ablain J, Mito JK, Yang S, Thomas A, Michael J, Fabo T, et al. Elife. 2021 Feb 2; 10. Epub 2021 Feb 2.